United Therapeutics Corporation (UTHR) Social Stream

Featured Post From StockTwits About UTHR

$MNKD

CC yesterday once again proves the company is in fantastic health & progressing as planned

🥭 MNKD Partners w/ NRx Pharmaceuticals To Explore A Dry Powder Formulation Of ZYESAMI

🥭 Tyvaso DPI FDA approval OCTOBER this year

🥭 >100 new MannKind jobs being added to Danbury, CT facility

🥭 Afrezza Peds Phase 3 this year

🥭 Clofazimine Phase 1 this year

🥭 Royalties from Thyquidity Co-Promote w/ Vertice Pharma starts NOW

🥭 MannKind and Thirona Bio Join Forces to Develop Inhaled Therapy for Fibrotic Lung Diseases

🥭 BluHale Pro Launch this year

🥭 Afrezza European Union filing this year—NO additional clinical trials required

🥭 Afrezza filing in Canada

🥭 Afrezza Australia approval this year

🥭 $100M+ in annual royalties from partner $UTHR for Tyvaso DPI

🥭 >$300M in cash—enough to get us to cash flow break even

🥭 Cannabis partner Receptor Life Sciences Phase 1 incoming

🥭 Afrezza India Clinical Trial this year

🥭 Medicare coverage for Afrezza Users obtaining CGMs

What Else are UTHR Traders Talking About?

Other tickers frequently mentioned alongside UTHR is MNKD.